🇺🇸 FDA
Patent

US 8536213

Oligomer-dantrolene conjugates and related compounds

granted A61KA61K47/60A61P

Quick answer

US patent 8536213 (Oligomer-dantrolene conjugates and related compounds) held by Nektar Therapeutics expires Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Sep 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K47/60, A61P, A61P25/00